N-[3-[[(3R)-3-(aminomethyl)pyrrolidin-1-yl]methyl]-5-(4-methylimidazol-1-yl)phenyl]-4-methyl-3-phenoxybenzamide

C30H33N5O2 — CID 135331332

IUPACN-[3-[[(3R)-3-(aminomethyl)pyrrolidin-1-yl]methyl]-5-(4-methylimidazol-1-yl)phenyl]-4-methyl-3-phenoxybenzamide
SMILESCc1cn(-c2cc(CN3CC[C@H](CN)C3)cc(NC(=O)c3ccc(C)c(Oc4ccccc4)c3)c2)cn1
InChIInChI=1S/C30H33N5O2/c1-21-8-9-25(14-29(21)37-28-6-4-3-5-7-28)30(36)33-26-12-24(19-34-11-10-23(16-31)18-34)13-27(15-26)35-17-22(2)32-20-35/h3-9,12-15,17,20,23H,10-11,16,18-19,31H2,1-2H3,(H,33,36)/t23-/m1/s1
InChIKeyHOJAATKXAUBAPY-HSZRJFAPSA-N
MW495.63 g/mol
LogP5.31
Rot. Bonds8

About N-[3-[[(3R)-3-(aminomethyl)pyrrolidin-1-yl]methyl]-5-(4-methylimidazol-1-yl)phenyl]-4-methyl-3-phenoxybenzamide

N-[3-[[(3R)-3-(aminomethyl)pyrrolidin-1-yl]methyl]-5-(4-methylimidazol-1-yl)phenyl]-4-methyl-3-phenoxybenzamide (PubChem CID 135331332) has the molecular formula C30H33N5O2 and a molecular weight of 495.63 g/mol. Its IUPAC name is N-[3-[[(3R)-3-(aminomethyl)pyrrolidin-1-yl]methyl]-5-(4-methylimidazol-1-yl)phenyl]-4-methyl-3-phenoxybenzamide.

Molecular Properties

Compound NameN-[3-[[(3R)-3-(aminomethyl)pyrrolidin-1-yl]methyl]-5-(4-methylimidazol-1-yl)phenyl]-4-methyl-3-phenoxybenzamide
PubChem CID135331332
Molecular FormulaC30H33N5O2
Molecular Weight495.63 g/mol
Exact Mass495.26
IUPAC NameN-[3-[[(3R)-3-(aminomethyl)pyrrolidin-1-yl]methyl]-5-(4-methylimidazol-1-yl)phenyl]-4-methyl-3-phenoxybenzamide
SMILESCc1cn(-c2cc(CN3CC[C@H](CN)C3)cc(NC(=O)c3ccc(C)c(Oc4ccccc4)c3)c2)cn1
InChIInChI=1S/C30H33N5O2/c1-21-8-9-25(14-29(21)37-28-6-4-3-5-7-28)30(36)33-26-12-24(19-34-11-10-23(16-31)18-34)13-27(15-26)35-17-22(2)32-20-35/h3-9,12-15,17,20,23H,10-11,16,18-19,31H2,1-2H3,(H,33,36)/t23-/m1/s1
InChIKeyHOJAATKXAUBAPY-HSZRJFAPSA-N
XLogP5.31
TPSA85.41 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500495.63
LogP ≤ 55.31
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze N-[3-[[(3R)-3-(aminomethyl)pyrrolidin-1-yl]methyl]-5-(4-methylimidazol-1-yl)phenyl]-4-methyl-3-phenoxybenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[3-[[(3R)-3-(aminomethyl)pyrrolidin-1-yl]methyl]-5-(4-methylimidazol-1-yl)phenyl]-4-methyl-3-phenoxybenzamide?
The IUPAC name of N-[3-[[(3R)-3-(aminomethyl)pyrrolidin-1-yl]methyl]-5-(4-methylimidazol-1-yl)phenyl]-4-methyl-3-phenoxybenzamide (CID 135331332) is N-[3-[[(3R)-3-(aminomethyl)pyrrolidin-1-yl]methyl]-5-(4-methylimidazol-1-yl)phenyl]-4-methyl-3-phenoxybenzamide.
What is the SMILES notation for N-[3-[[(3R)-3-(aminomethyl)pyrrolidin-1-yl]methyl]-5-(4-methylimidazol-1-yl)phenyl]-4-methyl-3-phenoxybenzamide?
The canonical SMILES for N-[3-[[(3R)-3-(aminomethyl)pyrrolidin-1-yl]methyl]-5-(4-methylimidazol-1-yl)phenyl]-4-methyl-3-phenoxybenzamide is Cc1cn(-c2cc(CN3CC[C@H](CN)C3)cc(NC(=O)c3ccc(C)c(Oc4ccccc4)c3)c2)cn1.
What is the InChIKey of N-[3-[[(3R)-3-(aminomethyl)pyrrolidin-1-yl]methyl]-5-(4-methylimidazol-1-yl)phenyl]-4-methyl-3-phenoxybenzamide?
The InChIKey is HOJAATKXAUBAPY-HSZRJFAPSA-N. The full InChI is InChI=1S/C30H33N5O2/c1-21-8-9-25(14-29(21)37-28-6-4-3-5-7-28)30(36)33-26-12-24(19-34-11-10-23(16-31)18-34)13-27(15-26)35-17-22(2)32-20-35/h3-9,12-15,17,20,23H,10-11,16,18-19,31H2,1-2H3,(H,33,36)/t23-/m1/s1.
What are the key properties of N-[3-[[(3R)-3-(aminomethyl)pyrrolidin-1-yl]methyl]-5-(4-methylimidazol-1-yl)phenyl]-4-methyl-3-phenoxybenzamide?
N-[3-[[(3R)-3-(aminomethyl)pyrrolidin-1-yl]methyl]-5-(4-methylimidazol-1-yl)phenyl]-4-methyl-3-phenoxybenzamide has a molecular weight of 495.63 g/mol, XLogP of 5.31, 8 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[[(3R)-3-(aminomethyl)pyrrolidin-1-yl]methyl]-5-(4-methylimidazol-1-yl)phenyl]-4-methyl-3-phenoxybenzamide is sourced from PubChem (CID 135331332), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).